Certain forms of myotonia, a condition characterized by delayed relaxation of muscle secondary to sarcolemmal hyperexcitability, are caused by diminished chloride conductance in the muscle cell membrane. We have investigated the molecular basis for decreased muscle chloride conductance in the myotonic goat, an historically important animal model for the elucidation of the role of chloride in muscle excitation. A single nucleotide change causing the substitution of proline for a conserved alanine residue in the carboxyl terminus of the goat muscle chloride channel (gCIC-1) was discovered. Heterologous expression of the mutation demonstrated a substantial (+47 mV) shift in the midpoint of steady-state activation of the channel, resulting in a diminished channel open probability at voltages near the resting membrane potential of skeletal muscle. These results provide a molecular basis for the decreased chloride conductance in myotonic muscle.
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Electrical excitation of the skeletal muscle cell membrane critically depends upon its ability to undergo rapid changes in selective ionic permeabilities that serve in the generation and propagation of action potentials. In a condition known as myotonia, abnormalities in specific sarcolemmal ion conductances can lead to a reduced electrical threshold for firing action potentials and in conduction of repetitive impulses that result in sustained muscle fiber contraction (1) . Myotonia is characterized clinically by delayed relaxation of muscle after sudden forceful contractions and is associated with a variety of acquired and hereditary diseases (2) . Congenital myotonia without associated weakness or muscular dystrophy can be transmitted as either an autosomal dominant (myotonia congenita or Thomsen disease) or recessive (recessive generalized myotonia or Becker myotonia) trait.
The current hypotheses regarding the pathophysiology of myotonia congenita were initially formulated from studies of the myotonic goat, an unusual breed afflicted with severe autosomal dominant congenital myotonia that closely resembles human Thomsen disease (3, 4) . These animals are often referred to as "fainting," "nervous," "stiff-legged," or "epileptic" goats because of their tendency to develop severe acute muscle stiffness and become immobile (and often fall) when attempting to make sudden forceful movements or when startled.
The pathogenesis of myotonia in the goat was elucidated by Bryant and colleagues (5, 6) who first described a severely diminished resting chloride conductance (gcl) in muscle fibers from affected animals. This group (7) also demonstrated that myotonia could be produced in normal skeletal muscle fibers bathed in a Cl--free solution. These important observations and subsequent studies contributed to the understanding of the role of gcl in normal sarcolemmal excitation and in the pathophysiology of myotonia. Many years later, molecular genetic studies on murine (8, 9) and human (10-13) myotonia confirmed structural and functional defects in a skeletal muscle chloride channel (termed CIC-1).
In view of the pivotal role played by the myotonic goat in establishing the pathophysiology of myotonia, we sought to define the molecular basis for diminished gcl in the myotonic goat by directly examining the ClC-1 muscle chloride channel for mutations. We report herein the discovery of a single nucleotide change in goat ClC-1 resulting in a missense mutation that causes a significant functional disturbance in the channel that fully explains decreased sarcolemmal gcl and the myotonic phenotype.
MATERIALS AND METHODS
Isolation of RNA. Skeletal muscle and other tissues were obtained from a phenotypically and electromyographically normal goat (wild type, WT) and from a myotonic goat (generously provided by V. LeQuire, Franklin, TN) taken from a colony that has been inbred for several generations. The colony consists of 13 goats from two successive generations, of which all are affected with severe myotonia. The affected animal used in the study exhibited prominent percussion and action myotonia, generalized muscular hypertrophy, and frequent bursts of repetitive discharges (myotonic runs) on an electromyograph. Protocols were approved by the Animal Care Committee of Vanderbilt University. Isolation of total and poly(A)+ RNA was performed with standard methods (14, 15 Extensions of the cDNA to the 5' end were made using either reverse transcriptase-coupled PCR or the 5' rapid amplification of cDNA ends (RACE) method (16) with modifications (17) . First-strand cDNA synthesis was performed with either random primers or a nondegenerate gene-specific primer (920RT, 5'-CAAAGGCGCTGAACGTGGCTGCA-A-3'). In reverse transcriptase-coupled PCR experiments, a degenerate forward primer based on the amino terminus of hClC-1 [56F, 5'-(C/A)CCCNCA(A/G)TA(T/C)CA(A/G)T-A(T/C)ATG-3'] was paired with a reverse nondegenerate goat ClC-1 (gClC-1) primer (897R, 5'-ATCCTCGCCAGTAGTT-CCTC-3'). In 5'-RACE experiments, PCR amplifications were done with a (dT)17-adaptor, a gene-specific primer (72R, 5'-AGTCCCAGGCGGTGCATACA-3', or 174R, 5'-GTTT-TGGCACTGACATAATC-3'), and a modified adaptor primer (5'-GACTCGAGTCGACATCGTT-3'). In each 5' cloning experiment, specific products were identified by Southern blot hybridization using a 32P-labeled hClC-1 cDNA probe, subcloned into plasmids, and sequenced by the Sanger dideoxynucleotide-mediated chain-termination method.
Single-Strand Conformational Analysis. First-strand synthesis was carried out with randomly primed total RNA (4 ,ug) from either normal or myotonic goat skeletal muscle. After first-strand cDNA synthesis, double-stranded cDNAs were amplified by two sequential PCRs. Initially, three overlapping regions (0.9-1 kb) of gClC-1 were amplified using three sets of primers. Each fragment was purified by spin column chromatography (Qiagen, Chatsworth, CA) and used as the template for the secondary PCRs containing nested primer pairs to produce 300-to 400-bp products. Each secondary PCR mixture (10 ,ul) contained 2 ,ul of the first-round PCR product, each primer at 0.5 ,tM, all four dNTPs (each at 70 ,uM), lx PCR buffer (10 mM Tris HCl, pH 8.9/50 mM KCl), 1.5-3.5 mM MgCl2 (optimized for each primer set), 0.1 Al of [a-32P]dCTP (3000 Ci/mmol; 1 Ci = 37 GBq), and 0.25 unit of Taq polymerase (5 units/,ul). Cycling conditions were initial denaturation of 8 min at 94°C, followed by 30 cycles of 94°C for 1 min, annealing temperature for 1 min (optimized for each primer set), and 72°C for 1 min. Products were denatured and then electrophoresed on nondenaturing 0.5 MDE gels (J.T. Baker) at 8 W for 16 h at 25°C. Abnormal conformers were excised from the dried gels, reamplified, and directly sequenced using fluorescein dye-labeled terminator chemistry on an Applied Biosystems model 373 automated sequencer. Genotyping was performed by MboII digestion of a 177-bp fragment PCR-amplified from genomic DNA (100 ng) using primers 2560F (5'-AGGAGCTGCAGAAGGCCATT-3') and 2717R (5'-TCATGTCCCCTGCCCCAGTG-3') with 35 cycles of 94°C for 1 min, 61°C for 1 min, and 72°C for 1 min.
Mutagenesis. Site-directed mutagenesis of hClC-1 was performed by overlap-extension PCR mutagenesis (18) using the following oligonucleotides: 2298F (5'-CATCTTCCAGTCCC-TGCTTC-3'), 2674R (5'-AAGTCGTGTTCCGGAAGCTG-GGAAGGGGAGGGCGGAGCT-3'), 2636F (5'-AGCTCC-GCCCTCCCCTTCCCAGCTTCCGGAACACGACTT-3'), and 2829R (5'-GAGGCGAATTCTAGACCCTATACCTTG-CCTGGG-3'). Final PCR products were digested with Sacl and Bsu36I, and a 392-bp fragment containing the mutation A885P was directionally ligated into the pSP64T-hClC-1 construct (13) . Presence of the mutation and absence of polymerase errors in the SacI-Bsu36I region in three independent recombinants were confirmed by dideoxynucleotide sequencing.
Functional Expression inXenopus Oocytes. Purified plasmid constructs of A885P-hCIC-1 and WT-hClC-1 were transcribed in vitro and expressed in Xenopus laevis oocytes as described (13) . Standard two-electrode voltage clamp recordings were made and analyzed as described (13) (Fig. 1) . Under reduced stringency conditions, the hClC-1 probe hybridized to an =3.6-kb transcript of near equal intensity in both normal and myotonic goat skeletal muscle total RNA but did not hybridize to RNA from goat brain, heart, liver, or kidney. A second weaker hybridization signal was also observed at -4.5 kb in both skeletal muscle lanes with near equal intensity. The latter signal is believed to result from either cross-hybridization to another mRNA species, presence of incompletely processed ClC-1 mRNA, or an undefined ClC-1 splice variant. These data indicate the presence of a ClC-1 homologue that is selectively expressed in muscle. The similarity of transcript sizes in normal and myotonic goat rules out large deletion or insertion mutations in this gene.
Having ruled out gross abnormalities in the size or expression levels of the mRNA, we searched for mutations at the level of nucleotide sequence. We constructed a cDNA library from myotonic goat skeletal muscle and cloned the myotonic goat skeletal muscle chloride channel cDNA. The longest of five positive cDNAs obtained from library screening (clone B8, 2. Physiology: Beck et aL Proc. Natl. Acad. Sci. USA 93 (1996) that terminated in a stop codon was identified. The other four positive clones were examined by restriction digest analysis, partially sequenced, and determined to be similar to B8. The nucleotide sequence of the open reading frame of B8 exhibits 87% identity with hClC-1 and 83% with rat ClC-1 but shares less identity with other CIC isoforms (61% with ClC-2, 53% with ClC-0, and 25% with ClC-3). The location of the stop codon corresponds to the stop codon present in hClC-1 (nt 2965). This was consistent with the sequence representing a partial-length goat ClC-1 cDNA (designated gClC-1). We used additional PCR techniques (reverse transcriptase-coupled PCR and 5'-RACE) to extend the sequence in the 5' direction. The 5' end was extended an additional 829 nt but did not reach a start codon. The assembled sequence of gClC-1 was found to encode a protein with 87% amino acid identity with hClC-1, 83% with rat ClC-1, and 48% with rat ClC-2. Inspection of the sequence aligned with hClC-1 revealed no obvious insertion, deletion, or nonsense mutations.
The absence of obvious discernable mutations at this stage in the analysis of gClC-1 necessitated a systematic approach to identify single nucleotide differences. To screen gClC-1 for single nucleotide mutations, we used single-strand conformational analysis (19) adapted for use with RNA as the starting material. Approximately 54% of the cDNA sequence of gClC-1 was screened by this method. An abnormal conformer was found in a segment encoding a portion of the carboxyl terminus of the channel (Fig. 2A4) . Conformers from both the WT and myotonic samples were eluted from the gel, reamplified using PCR, and directly sequenced on both strands. Two sequence differences between WT and myotonic samples were identified. One difference was a T --C transition in the myotonic sample that does not result in an amino acid change and is most likely a polymorphism. We also detected a G -+ C transversion in the myotonic sample (Fig. 2B) occur in the carboxyl terminus of gClC-1 104 amino acids from the termination codon (corresponding to amino acid 885 in hClC-1). This transversion creates a new MboII restriction site thus providing the basis for an allele-specific assay. A 177-bp region containing this sequence variant was amplified from genomic DNA obtained from the other members of the myotonic goat colony and 11 additional normal goats. Digestion of this product amplified from normal goat DNA with MboII produces two bands of 105 and 72 bp, whereas digestion of DNA from all of the myotonic goats results in three bands (72, 53, and 52 bp), indicating the presence of the sequence variant in all members of the inbred colony (Fig. 2D) . The absence of the 105-bp fragment further indicates that each myotonic goat is homozygous for the transversion. This sequence variant occurs within a 7-amino acid segment that is completely conserved in the carboxyl terminus of ClC-1 (all species), ClC-2, and ClC-0 (Fig. 2C) , and is, therefore, a candidate mutation.
If this sequence variant is a mutation, then we expect the mutant allele to exhibit a functional abnormality sufficient to explain the decreased gcl observed in myotonic muscle. To ascertain the functional consequences of this substitution, we engineered the mutation (A885P) in hClC-1 and examined its functional properties in Xenopus oocytes by two-electrode voltage clamp recording. Fig. 3 shows representative traces of WT hClC-1 and the A885P mutant along with their respective current-voltage relationships. Peak current amplitudes were similar in both WT and A885P expressing oocytes, indicating similar expression levels of the two alleles. Upon hyperpolarization, the WT channel (Fig. 3A) deactivates to a non-zero steady-state level. With more depolarizing potentials, the steady-state current amplitude first increases and then decreases, producing the cross-over pattern that is characteristic of ClC-1 at negative potentials (13, 20) . At potentials positive to -65 mV, the current is almost time-independent. The A885P mutant (Fig. 3B ) also deactivates to a constant level upon hyperpolarization, but the "crossing over" of the steadystate current amplitude is less pronounced and occurs at potentials positive to -30 mV (versus -65 mV for WT). Upon depolarizing test potentials, there is a more pronounced time-dependent increase of the current amplitude with the A885P mutant than with WT. Fig. 3 C and D show the current-voltage relationships for WT and A885P. The instantaneous current is inwardly rectifying for both WT and mutant and mean instantaneous current amplitudes are not different. Currents for both WT and A885P "cross over" at -30 mV, which is the reversal potential for Clin these experiments. In contrast, the voltage dependence of the steady-state current for A885P is different from WT. Whereas with WT, instantaneous and steady-state current amplitudes are identical at potentials positive to the Clequilibrium potential, A885P current amplitudes at the end of the test pulse are larger than the instantaneous values.
The results presented in Fig. 3 suggest a difference in the voltage dependence of gating between WT and the A885P mutant. Therefore, we evaluated the steady-state activation of the WT and mutant channels at voltages ranging from -145 mV to +35 mV by comparing their relative open probabilities (Fig. 4) . In these experiments, the A885P mutant channel exhibits a dramatic and significant +47-mV shift in the midpoint of steady-state activation [WT, -64.1 ± 6.0 mV (n = 4); A885P, -17.2 ± 7.7 mV (n = 6);p < 0.005), but no change in slope factor (see Fig. 4 ). This shift results in a substantially decreased open probability of the mutant relative to WT within the physiological voltage range and is the likely cause of the decreased gcl in myotonic muscle. Therefore, the alanine to proline substitution identified in the myotonic goat ClC-1 carboxyl terminus is consistent with a mutation causing myotonia. 
DISCUSSION
In this paper we have defined the molecular genetic basis of myotonia that occurs in the goat and demonstrate the functional consequences of the disease-producing mutation using a recombinant chloride channel. The mutation we described causes the substitution of a highly conserved alanine residue with proline within the predicted cytoplasmic carboxyl terminus region of the ClC-1 protein. This missense mutation occurs within a short sequence of 7 amino acids that is completely conserved in a group of closely related CIC channels including human and rat ClC-1 (10, 21), ClC-2 (22) , and the Torpedo electroplax channel ClC-0 (23), although many subfamilies of ClC channels lack homology to ClC-1 within the carboxyl terminus (24) (25) (26) (27) . Other myotonia-producing mutations have been described in the human ClC-1 carboxyl terminus including two nonsense mutations (ref. 28 and unpublished observations).
In the absence of a full-length gClC-1 cDNA, the functional consequences of the myotonic goat ClC-1 mutation were studied in the well-characterized human homologue hClC 
test).
To normalize the maximum relative Pp,,n, the data points were scaled so that the fitted function had an asymptote of unity. Data are means ± SEM; n = 4 (WT) and n = 6 (A885P). (7) . Normally, this rise in extracellular potassium in the t-tubules has little effect on membrane potential due to the shunting effect of a high sarcolemmal gcl. By contrast in myotonic muscle, the rise in t-tubular potassium has a 10-fold greater effect on the membrane potential and results in a significant degree of depolarization after action potential termination ("after-depolarization"). If sufficient numbers of impulses are propagated rapidly in the t-tubule, then the after-depolarization can achieve threshold voltage and cause the spontaneous triggering of action potentials independent of neuromuscular transmission. These events will result in clinical myotonia.
With definition of the molecular defect responsible for the myotonic goat, our work provides a direct explanation for the sentinel observations made by Bryant and colleagues (5, 6) more than three decades ago and contributes to the union of cellular and molecular physiology in understanding myotonia.
